Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages

BJU International

Volumn 113, Issue 2, 2014, Pages 333-342

  Descotes, Françoise ^a   Dessen, Philippe ^b   Bringuier, Pierre Paul ^c   Decaussin, Myriam ^a,d   Martin, Pierre Marie ^e   Adams, Marjorie ^a   Villers, Arnauld ^f   Lechevallier, Eric ^g   Rebillard, Xavier ^h   Rodriguez Lafrasse, Claire ^a   Devonec, Marian ^a   Paparel, Philippe ^a   Perrin, Paul ^a   Lazar, Vladimir ^b   Ruffion, Alain ^a,d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITÉ LYON 1   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^f UNIV LILLE   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

^h Clinique Beau Soleil   (France)

Author keywords

bladder; carcinoma; invasive; microarray; pT1a stage; pT1b stage; superficial

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; BIOCHEMICAL EQUIPMENT; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

BLADDER; CARCINOMA; INVASIVE; MICROARRAY; PT1A STAGE; PT1B STAGE; SUPERFICIAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84892530332     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12364     Document Type: Article

References (30)

1. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51: 3-30
2. Fritsche HM, Burger M, Svatek RS, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010; 57: 300-309
3. Smith SC, Baras AS, Dancik G, et al. A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. Lancet Oncol 2011; 12: 137-143
4. Mitra AP, Pagliarulo V, Yang D, et al. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 2009; 27: 3929-3937
5. Williams PD, Cheon S, Havaleshko DM, et al. Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy. Cancer Res 2009; 69: 8302-8309
6. Pfister C, Roupret M, Wallerand H, et al. Recommendations Onco-Urology 2010: urothelial tumors. Prog Urol 2010; 20 (Suppl. 4): S255-274
7. Richard S, Amy L, Ming-Chung L, Michael N, Supriya M, Yingdong Z,. Analysis of gene expression data using BRB-array tools. Cancer Inform 2007; 3: 11-17
8. Li C, Wong WH,. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-36
9. Billerey C, Sibony M,. So-called 'superficial' bladder tumors. Which classification in 2003? Part 1: papillary tumors. Ann Pathol 2003; 23: 21-33
10. Chopin DK, Gattegno B,. Superficial bladder tumors. Eur Urol 2002; 42: 533-541
11. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66: 4-34
12. Montironi R, Lopez-Beltran A,. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005; 13: 143-153
13. Seitz M, Zaak D, Knuchel-Clarke R, Stief C,. Urinary bladder tumours. The new 2004 WHO classification. Urologe A 2005; 44: 1073-1086
14. Bol MG, Baak JP, Buhr-Wildhagen S, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003; 169: 1291-1294
15. Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T,. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 2007; 78: 338-344
16. Lopez-Beltran A, Algaba F, Berney DM, et al. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2011; 58: 579-585
17. May M, Brookman-Amissah S, Roigas J, et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol 2010; 57: 850-858
18. Sharkey FE, Sarosdy MF,. The significance of central pathology review in clinical studies of transitional cell carcinoma in situ. J Urol 1997; 157: 68-70
19. Tosoni I, Wagner U, Sauter G, et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000; 85: 48-53
20. van Rhijn BW, van Leenders GJ, Ooms BC, et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur Urol 2010; 57: 1052-1057
21. Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjot L, Orntoft TF,. Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 2005; 93: 1182-1190
22. Blaveri E, Simko JP, Korkola JE, et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005; 11: 4044-4055
23. Dyrskjot L, Thykjaer T, Kruhoffer M, et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 2003; 33: 90-96
24. Kawakami K, Enokida H, Tachiwada T, et al. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 2006; 16: 521-531
25. Mengual L, Burset M, Ars E, et al. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. J Urol 2009; 182: 741-748
26. Modlich O, Prisack HB, Pitschke G, et al. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin Cancer Res 2004; 10: 3410-3421
27. Orsola A, Trias I, Raventos CX, et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005; 48: 231-238
28. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA,. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998; 52: 1009-1013
29. Faivre d'Arcier B, Celhay O, Safsaf A, et al. T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU). Prog Urol 2010; 20: 440-449
30. Lauss M, Ringner M, Hoglund M,. Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study. Clin Cancer Res 2010; 16: 4421-4433